Terapias Avanzadas para Tumores Sólidos Pediátricos
![Foto de Terapias Avanzadas para Tumores Sólidos Pediátricos](/img/uploaded/b208e5bd76d11417a3039a0beab16391.jpg)
![Foto de University of Lausanne](/img/noimage_org.png)
University of Lausanne
Lausana, SuizaPublicaciones en colaboración con investigadores/as de University of Lausanne (2)
2021
-
CD40 agonist targeted to fibroblast activation protein a synergizes with radiotherapy in murine HPV-positive head and neck tumors
Clinical Cancer Research, Vol. 27, Núm. 14, pp. 4054-4065
-
Fibroblast activation protein a-targeted CD40 agonism abrogates systemic toxicity and enables administration of high doses to induce effective antitumor immunity
Clinical Cancer Research, Vol. 27, Núm. 14, pp. 4036-4053